SecBot SecBot
Insider Cluster (2 insiders) ·Filed Aug 12, 2026

HEPA

Hepion Pharmaceuticals, Inc.
BULLISH
Impact 6/10
Horizonweeks Processed2mo ago
Insider cluster: 2 insiders, $125K total
Actionable Insight ▲ Bullish

The CEO's $100K open-market buy is a strong conviction signal at a distressed price of $0.05. Monitor for upcoming catalysts such as pipeline updates or financing news. The cluster buy, combined with the prior 30-day buying spree, suggests insiders see value below current levels. A move above $0.10 would confirm bullish momentum.

DirectionBullish
Confidencemedium
Horizonweeks
Latest settled — T+20d
HEPA ▼ -21.43% at T+20d
LONG call ✗ call lost -21.43% · α vs SPY -19.68% · entry $0.0700 → $0.0550
Next anchor: T+60d in 10d
Latest observation: T+50 +137.05% FF3 residual α
Entry = T+0 close
Aug 12, 2026
via day close
T+1d
+7.14%
call +7.14% · α +7.34%
$0.0750
settled 2mo ago
T+5d
-12.86%
call -12.86% · α -10.89%
$0.0610
settled 2mo ago
T+20d
-21.43%
call -21.43% · α -19.68%
$0.0550
settled 7w ago
T+60d
Pending
in 10d

Price Chart

Loading chart...

Executive Summary

Two Hepion insiders, including the Interim CEO and a director, purchased a total of $125K in HEPA shares at $0.05 each on August 3, 2026. This cluster buy is a strong bullish signal, especially from the CEO, and aligns with a 30-day trend of $700K in insider buying. The purchases represent a material 0.04% of the company's market cap, but the signal is amplified by the CEO's participation and the cluster context.

Key Financial Metrics

Direction
buying
Total Value
$125.0K
Insiders
2

Key Facts

  • Interim CEO Gary S. Stetz bought 2M shares for $100K at $0.05/share on 2026-08-03.
  • Director Gary S. Stetz II bought 500K shares for $25K at $0.05/share on 2026-08-03.
  • Total cluster value: $125K, all open-market purchases.
  • Prior 30-day insider buying totaled $700K across 10 buys.
  • Stock trades OTC with 86% analyst bullish consensus.

Financial Impact

$125K in insider purchases, representing ~0.04% of market cap.

insider ownershipmarket sentiment

Risk Factors

  • OTC-listed micro-cap with high bankruptcy risk; $125K is a small absolute amount.
  • No revenue or near-term catalyst identified in the filing.

Market Snapshot

Exchange
OTC
Sector
Pharmaceutical Preparations
Analyst Consensus
86% bullish (7 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-HEPA-1786586475657
6 reports for HEPA
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for HEPA — sortable, filterable
TypeNow
Oct 21, 2026
5d ago
SC 13G/A
NEUTRAL ★ 3/10
$0.1350awaiting T+20—$0.1281 (−5.11%)
Oct 9, 2026
17d ago
8-K
MIXED ★ 6/10
$0.1240awaiting T+20—$0.1281 (+3.31%)
Sep 28, 2026
28d ago
8-K
BEARISH ★ 6/10
$0.0800 $0.1281▼ −60.13%▼ −60.16%$0.1281 (−60.12%)
Aug 12, 2026
10w ago
Insider Cluster
BULLISH ★ 6/10
$0.0700 $0.0550▼ −21.43%▼ −19.68%$0.1281 (+83.00%)
Apr 21, 2026
26w ago
Insider Cluster
MIXED ★ 5/10
$0.0700 $0.0750▲ +7.14%▲ +1.67%$0.1281 (+83.00%)
Apr 21, 2026
26w ago
Insider Cluster
MIXED ★ 6/10
$0.0620 $0.0750▲ +20.97%▲ +16.01%$0.1281 (+106.61%)
Showing 6 of 6

US Market Status

Market Closed — Opens Tue (16h 1m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 12, 2026